KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in Net LoansDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omega Healthcare Investors (OHI) Gains from Investment Securities (2016 - 2025)

Omega Healthcare Investors' Gains from Investment Securities history spans 14 years, with the latest figure at $15.7 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 2372.29% year-over-year to $15.7 million; the TTM value through Dec 2025 reached $22.5 million, up 1360.92%, while the annual FY2025 figure was $26.3 million, 1608.78% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was $15.7 million at Omega Healthcare Investors, up from $6.2 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $91.0 million in Q3 2021 and bottomed at -$24.4 million in Q2 2021.
  • The 4-year median for Gains from Investment Securities is $919500.0 (2023), against an average of $14.2 million.
  • The largest annual shift saw Gains from Investment Securities crashed 215.5% in 2024 before it soared 2372.29% in 2025.
  • A 4-year view of Gains from Investment Securities shows it stood at $70.6 million in 2021, then tumbled by 99.15% to $600000.0 in 2023, then plummeted by 215.5% to -$693000.0 in 2024, then skyrocketed by 2372.29% to $15.7 million in 2025.
  • Per Business Quant, the three most recent readings for OHI's Gains from Investment Securities are $15.7 million (Q4 2025), $6.2 million (Q3 2025), and $22040.0 (Q2 2025).